Isis Pharmaceuticals Announces Positive Phase 2 Results In Patients With Spinal Muscular Atrophy

Shares of Isis are up 4% after posting positive phase 2 results in patients with Spinal Muscular Atrophy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.